Table 7.

Association between in-hospital mortality and the acute kidney injury stages in diagnosed by Creatinine kinetics, “Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease”, Acute Kidney Injury Network, and Kidney Disease Improving Global Outcomes

Variables		Univariable analysis		Multivariable analysis
		Odds ratio (95%CI)	P value	Odds ratio (95%CI)	P value
KDIGO	Stage 1	1.64 (1.11-2.41)	0.013	0.70 (0.27-1.83)	0.635
	Stage 2	2.51 (1.33-4.71)	0.004	0.15 (0.00-4.76)	0.242
	Stage 3	5.65 (2.92-10.93)	< 0.001	0.10 (0.00-7.83)	0.705
RIFLE	Stage 1	1.86 (1.16, 2.96)	0.010	0.97 (0.39-2.43)	0.879
	Stage 2	2.70 (1.48-4.90)	0.001	3.26 (0.18-59.43)	0.166
	Stage 3	6.14 (3.08-12.25)	< 0.001	1.90 (0.07-49.94)	0.466
AKIN	Stage 1	1.77 (1.21-2.59)	0.004	1.32 (0.39-4.40)	0.933
	Stage 2	2.54 (1.32-4.88)	0.005	3.23 (0.33-31.98)	0.552
	Stage 3	6.25 (3.13-12.49)	< 0.001	16.88 (0.74-349.18)	0.403
CK	Stage 1	1.49 (0.89-2.51)	0.132	1.34 (0.44-4.83)	0.500
	Stage 2	2.49 (1.32-4.70)	0.005	1.07 (0.35-3.25)	0.579
	Stage 3	4.40 (2.20-8.79)	< 0.001	0.72 (0.17-2.98)	0.615

ORs are adjusted for ethnicity, age, sex, Elixhauser score, simplified acute physiology score, SOFA, Glasgow Coma Scale, craniotomy, max creatinine, creatinine at admission, use of antiplatelet drugs, anticoagulant, vancomycin, angiotensin receptor blocker/angiotensin-converting enzyme inhibitor and aminoglycosides, transfusion, red blood cell, plasma and shock. P values < 0.05 were considered statistically significant. KDIGO: Kidney Disease Improving Global Outcomes; AKIN: Acute Kidney Injury Network; RIFLE: Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease; CK: Creatinine kinetics; CI: Confidence interval.